258 related articles for article (PubMed ID: 1853824)
21. Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study.
Sehgal SS; Ewing CK; Richards T; Taeusch HW
J Natl Med Assoc; 1994 Jan; 86(1):46-52. PubMed ID: 8151722
[TBL] [Abstract][Full Text] [Related]
22. Respiratory distress syndrome in New Zealand: evidence from the OSIRIS trial of exogenous surfactant (Exosurf).
Wach R; Darlow B; Bourchier D; Broadbent R; Knight D; Selby R
N Z Med J; 1994 Jun; 107(980):234-7. PubMed ID: 8208494
[TBL] [Abstract][Full Text] [Related]
23. Changes in pulmonary artery pressure during the acute phase of respiratory distress syndrome treated with three different types of surfactant.
Hamdan AH; Shaw NJ
Pediatr Pulmonol; 1998 Mar; 25(3):191-5. PubMed ID: 9556011
[TBL] [Abstract][Full Text] [Related]
24. Reduced mortality in small premature infants treated at birth with a single dose of synthetic surfactant.
Corbet AJ; Long WA; Murphy DJ; Garcia-Prats JA; Lombardy LR; Wold DE
J Paediatr Child Health; 1991 Aug; 27(4):245-9. PubMed ID: 1958425
[TBL] [Abstract][Full Text] [Related]
25. Mucus rheology and transport in neonatal respiratory distress syndrome and the effect of surfactant therapy.
Rubin BK; Ramirez O; King M
Chest; 1992 Apr; 101(4):1080-5. PubMed ID: 1555424
[TBL] [Abstract][Full Text] [Related]
26. Changes in pulmonary artery pressure in infants with respiratory distress syndrome following treatment with Exosurf.
Hamdan AH; Shaw NJ
Arch Dis Child Fetal Neonatal Ed; 1995 May; 72(3):F176-9. PubMed ID: 7796233
[TBL] [Abstract][Full Text] [Related]
27. Comparing surfactant products.
Prevost RR
Clin Pharm; 1991 Dec; 10(12):909, 911. PubMed ID: 1773577
[No Abstract] [Full Text] [Related]
28. Surfactant and respiratory distress syndrome.
Milner AD
Turk J Pediatr; 1996; 38(1):37-43. PubMed ID: 8819619
[TBL] [Abstract][Full Text] [Related]
29. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. National Institute of Child Health and Human Development Neonatal Research Network.
Horbar JD; Wright LL; Soll RF; Wright EC; Fanaroff AA; Korones SB; Shankaran S; Oh W; Fletcher BD; Bauer CR
J Pediatr; 1993 Nov; 123(5):757-66. PubMed ID: 8229487
[TBL] [Abstract][Full Text] [Related]
30. Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I.
Stevenson D; Walther F; Long W; Sell M; Pauly T; Gong A; Easa D; Pramanik A; LeBlanc M; Anday E
J Pediatr; 1992 Feb; 120(2 Pt 2):S3-12. PubMed ID: 1735849
[TBL] [Abstract][Full Text] [Related]
31. Elastase activity and surfactant protein concentration in tracheal aspirates from neonates receiving synthetic surfactant.
Gerdes J; Whitsett J; Long W
J Pediatr; 1992 Feb; 120(2 Pt 2):S34-9. PubMed ID: 1735850
[TBL] [Abstract][Full Text] [Related]
32. OSIRIS trial.
Tarnow-Mordi W
Lancet; 1993 Jan; 341(8838):174. PubMed ID: 8093765
[No Abstract] [Full Text] [Related]
33. [Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
Robertson B; Sangstad OD
Tidsskr Nor Laegeforen; 1994 Feb; 114(5):590-1. PubMed ID: 8209345
[No Abstract] [Full Text] [Related]
34. Single dose surfactant rescue therapy in neonatal respiratory distress syndrome.
Sanghvi KP; Merchant RH
Indian Pediatr; 1998 Jun; 35(6):533-6. PubMed ID: 10216648
[No Abstract] [Full Text] [Related]
35. Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant.
Bhutani VK; Abbasi S; Long WA; Gerdes JS
J Pediatr; 1992 Feb; 120(2 Pt 2):S18-24. PubMed ID: 1735846
[TBL] [Abstract][Full Text] [Related]
36. Lung function in prematurely delivered rabbits treated with a synthetic surfactant.
Tooley WH; Clements JA; Muramatsu K; Brown CL; Schlueter MA
Am Rev Respir Dis; 1987 Sep; 136(3):651-6. PubMed ID: 3307569
[TBL] [Abstract][Full Text] [Related]
37. Postnatal changes in pulmonary mechanics and energetics of infants with respiratory distress syndrome following surfactant treatment.
Bhutani VK; Bowen FW; Sivieri EM
Biol Neonate; 2005; 87(4):323-31. PubMed ID: 15985755
[TBL] [Abstract][Full Text] [Related]
38. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
[TBL] [Abstract][Full Text] [Related]
39. Effect of intra-amniotic administration of Exosurf in preterm rabbit fetuses.
Galan HL; Kuehl TJ
Obstet Gynecol; 1992 Oct; 80(4):604-8. PubMed ID: 1407880
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary hemorrhage in premature infants after treatment with synthetic surfactant: an autopsy evaluation. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
van Houten J; Long W; Mullett M; Finer N; Derleth D; McMurray B; Peliowski A; Walker D; Wold D; Sankaran K
J Pediatr; 1992 Feb; 120(2 Pt 2):S40-4. PubMed ID: 1735851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
